194 related articles for article (PubMed ID: 36880167)
1. Clinical implications and molecular features of tertiary lymphoid structures in stage I lung adenocarcinoma.
Xu X; Gao Y; Duan S; Ding Q; Wang X; Dai X; Zhang Y; Chen Y; Chen D
Cancer Med; 2023 Apr; 12(8):9547-9558. PubMed ID: 36880167
[TBL] [Abstract][Full Text] [Related]
2. The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.
Tamiya Y; Nakai T; Suzuki A; Mimaki S; Tsuchihara K; Sato K; Yoh K; Matsumoto S; Zenke Y; Nosaki K; Izumi H; Shibata Y; Sakai T; Taki T; Miyazaki S; Watanabe R; Sakamoto N; Sakashita S; Kojima M; Hashimoto N; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2022 Dec; 174():125-132. PubMed ID: 36379125
[TBL] [Abstract][Full Text] [Related]
3. The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
Xie M; Gao J; Ma X; Song J; Wu C; Zhou Y; Jiang T; Liang Y; Yang C; Bao X; Zhang X; Yao J; Jing Y; Wu J; Wang J; Xue X
BMC Cancer; 2024 Mar; 24(1):372. PubMed ID: 38528507
[TBL] [Abstract][Full Text] [Related]
4. Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer.
Xiaoxu D; Min X; Chengcheng C
BMC Pulm Med; 2024 Mar; 24(1):155. PubMed ID: 38532454
[TBL] [Abstract][Full Text] [Related]
5. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Resident T Cells, Associated With Tertiary Lymphoid Structure Maturity, Improve Survival in Patients With Stage III Lung Adenocarcinoma.
Zhao H; Wang H; Zhao Y; Sun Q; Ren X
Front Immunol; 2022; 13():877689. PubMed ID: 35663939
[TBL] [Abstract][Full Text] [Related]
7. Investigating Tumor-Associated Tertiary Lymphoid Structures in Murine Lung Adenocarcinoma.
Connolly KA; Nader M; Joshi N
Methods Mol Biol; 2018; 1845():259-273. PubMed ID: 30141018
[TBL] [Abstract][Full Text] [Related]
8. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors.
Zhao Z; Ding H; Lin ZB; Qiu SH; Zhang YR; Guo YG; Chu XD; Sam LI; Pan JH; Pan YL
Int J Med Sci; 2021; 18(11):2327-2338. PubMed ID: 33967609
[No Abstract] [Full Text] [Related]
10. Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.
Wang D; Huang L; Qian D; Cao Y; Wu X; Xu P; Ming L; Tang J; Huang Z; Yin Y; Zhou L
Front Immunol; 2023; 14():1334408. PubMed ID: 38259481
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.
Wakasu S; Tagawa T; Haratake N; Kinoshita F; Oku Y; Ono Y; Takenaka T; Oda Y; Shimokawa M; Mori M
Cancer Immunol Immunother; 2023 Jun; 72(6):1823-1834. PubMed ID: 36688996
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma.
Feng H; Yang F; Qiao L; Zhou K; Wang J; Zhang J; Tian T; Du Y; Shangguan H
Front Oncol; 2021; 11():693234. PubMed ID: 34381716
[TBL] [Abstract][Full Text] [Related]
13. Characterization of lung adenocarcinoma with a cribriform component reveals its association with spread through air spaces and poor outcomes.
Ding Q; Chen D; Wang X; Wen J; Chen C; Zhang Y; Xu Z; Chen Y
Lung Cancer; 2019 Aug; 134():238-244. PubMed ID: 31319987
[TBL] [Abstract][Full Text] [Related]
14. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
Front Immunol; 2022; 13():962056. PubMed ID: 36189233
[TBL] [Abstract][Full Text] [Related]
15. High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer.
Zhan Z; Shi-Jin L; Yi-Ran Z; Zhi-Long L; Xiao-Xu Z; Hui D; Pan YL; Pan JH
Ann Med; 2023 Dec; 55(1):114-126. PubMed ID: 36503344
[TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer.
Rakaee M; Kilvaer TK; Jamaly S; Berg T; Paulsen EE; Berglund M; Richardsen E; Andersen S; Al-Saad S; Poehl M; Pezzella F; Kwiatkowski DJ; Bremnes RM; Busund LR; Donnem T
Br J Cancer; 2021 May; 124(10):1680-1689. PubMed ID: 33723388
[TBL] [Abstract][Full Text] [Related]
17. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X
J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521
[TBL] [Abstract][Full Text] [Related]
18. Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors.
Zhang WH; Wang WQ; Han X; Gao HL; Xu SS; Li S; Li TJ; Xu HX; Li H; Ye LY; Lin X; Wu CT; Long J; Yu XJ; Liu L
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33055204
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.
Chen D; Ding Q; Wang W; Wang X; Wu X; Mao Y; Chen C; Chen Y; Zhang Y
Ann Surg Oncol; 2021 Apr; 28(4):2088-2098. PubMed ID: 33015723
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
